AKT1 and central nervous system cancer: The results indicated that the PI3K/AKT signaling pathway was induced by L1 overexpression, whereas treatment with the miR‐143‐3p mimic significantly inactivated PI3K/AKT signaling regardless of L1 overexpression in the T98 and GBM1 glioma cell lines (Fig. 7A).